,,iii #aad? ,,congress #a/ ,session ,s4 ,,res4 #bdb ,,9 ,,! ,,s5ate ,,( ,,! ,,unit$ ,,/ates ,augu/ #e1 #bjae ,ms4 ,mikulski 7= h]self & ,ms4 ,coll9s7 submitt$ ! foll[+ resolution2 :i* 0 ref]r$ to ! ,committee on ,heal?1 ,education1 ,labor1 & ,p5sions ,,resolution ,celebrat+ #be ye>s ( success f ! ,(fice ( ,rese>* on ,wom5's ,heal? at ! ,national ,in/itutes ( ,heal?4 ,:]eas1 on ,septemb] #aj1 #aiij1 ! ,(fice ( ,rese>* on ,wom5's ,heal? 79 ?is resolution ref]r$ to z ,,or:7 0 e/abli%$ at ! ,national ,in/itutes ( ,heal? 79 ?is resolution ref]r$ to z ,,nih7 to-- 7#a7 ensure t wom5 7 includ$ 9 ,,nih-fund$ cl9ical rese>*2 7#b7 set rese>* priorities to address gaps 9 sci5tific k2 & 7#c7 promote biom$ical rese>* c>e]s = wom52 ,:]eas ,,or: 0 e/abli%$ 9 law by ! ,national ,in/itutes ( ,heal? ,revitalization ,act ( #aiic 7,public ,law #ajc-dc2 #ajg ,/at4 #abb7 & implem5t$ ! law requir+ rese>*]s to include wom5 9 ,,nih-fund$ te/s ( new drugs & o!r cl9ical trials2 ,:]eas1 today1 m ?an #a_/b ( ! p>ticipants 9 ,,nih-fund$ cl9ical trials are wom51 enabl+ ! developm5t ( cl9ical approa*es to prev5tion1 diagnosis1 or treatm5t appropriate = wom52 ,:]eas1 9 #bjae1 ,,or:1 ) en?usia/ic support f ,,nih lead]%ip1 ann\nc$ t1 beg9n+ 9 ,janu>y #bjaf1 ,,nih-fund$ sci5ti/s mu/ acc\nt = ! possible role ( sex z a biological v>iable 9 v]tebrate animal & human /udies2 ,:]eas ,,or:1 along ) ,,nih lead]%ip1 enhances aw>5ess ( ! ne$ to adh]e to pr9ciples ( rigor & transp>5cy1 includ+ ! ne$ to publi% sex-specific results to in=m ! treatm5t ( wom51 m51 boys1 & girls2 ,:]eas1 ov] ! pa/ #be ye>s1 ,,or: has help$ exp& rese>* on wom5's heal? beyond its roots 9 reproductive heal? to include-- 7#a7 ! /udy ( ! heal? ( wom5 across ! lifespans ( wom52 & 7#b7 biom$ical & behavioral rese>* f cells to selves2 ,:]eas1 by /udy+ bo? sexes1 ,,or: is lead+ ! sci5tific community to make discov]ies head$ t[>d treatm5ts t are m p]sonaliz$ = bo? wom5 & m52 ,:]eas1 today1 ,,or: communicates ?r\gh programs & policies t sex & g5d] affect heal?1 wellness1 & h[ diseases progress2 ,:]eas turn+ discov]y into heal? = all1 ! ,,nih motto1 means /udy+ bo? females & males across ! biom$ical rese>* cont9uum2 ,:]eas ! ,,or: ,specializ$ ,c5t]s ( ,rese>* on ,sex ,diff]5ces program supports e/abli%$ sci5ti/s :o d basic1 cl9ical1 & translational rese>* ) a sex & g5d] focus2 ,:]eas all ,,nih ,in/itutes & ,c5t]s fund & enc\rage sci5ti/s at univ]sities across ! ,nation to conduct rese>* on ! heal? ( wom5 & on sex & g5d] influ5ces2 ,:]eas1 ov] ! pa/ #be ye>s1 ,,or: has e/abli%$ sev]al c>e]-enhancem5t initiatives = wom5 9 biom$ic9e1 includ+ ! ,build+ ,int]discipl9>y ,rese>* ,c>e]s 9 ,wom5's ,heal? program t connects junior faculty ) m5tors :o %>e int]e/s 9 wom5's heal? rese>*2 ,:]eas ,,or: co-directs ! ,,nih ,work+ ,gr\p on ,wom5 9 ,biom$ical ,c>e]s1 :i* develops & evaluates policies to promote ! recruitm5t1 ret5tion1 & su/a9$ advancem5t ( wom5 sci5ti/s2 ,:]eas ! ,wom5's ,heal? ,initiative 79 ?is resolution ref]r$ to z ,,:i7 m>k$ ! fir/ long-t]m /udy ( its k9d & result$ 9 a weal? ( in=mation s t wom5 & _! physicians c make m in=m$ decisions reg>d+ po/m5opausal hormone !rapy2 ,:]eas ,,:i r$uc$ ! incid5ce ( brea/ canc] by #aj1jjj to #ae1jjj cases p] ye>1 & ! ov]all heal? c>e sav+s f> exce$$ ! ,,:i inve/m5t2 ,:]eas ,,or: support$ ! ,national ,canc] ,in/itute's developm5t ( a vacc9e t prev5ts ! transmission ( ,human ,papilloma ,virus1 result+ 9 a decrease 9 ! numb] ( cases ( c]vical canc]2 ,:]eas1 9 #aiid1 ,,or: co-sponsor$ ) ! ,national ,in/itute ( ,all]gy & ,infecti\s ,diseases a l&m>k /udy1 ! results ( :i* %[$ t giv+ ! drug ,,azt to ,,hiv-infect$ wom5 ) little or no prior antiretroviral !rapy r$uc$ ! risk ( "m-to-*ild transmission ( ,,hiv by #b_/c2 ,:]eas1 accord+ to ! ,,cdc1 p]9atal ,,hiv infections 9 ! ,unit$ ,/ates h dropp$ by m ?an #ij p]c5t2 ,:]eas ,,or: co-fund$ a l>ge cl9ical /udy ( ! g5etic & environm5tal risk factors = is*emic /roke1 :i* id5tifi$ a /rong relation%ip betwe5 ! numb] ( cig>ettes smok$ p] day & ! probability ( is*emic /roke 9 "y wom51 prompt+ ! t>get+ ( smok+ z a prev5table & modifiable risk factor = c]ebrovascul> disease 9 "y wom52 & ,:]eas1 ov] ! pa/ #be ye>s1 ,,or: has contribut$ support t[>d major advances 9 k ab\t ! g5etic risk = brea/ canc]1 & discov]y ( ! ,,brca#a & ,,brca#b g5etic risk m>k]s has enabl$ bett]-in=m$ g5etic c\nsel+ & treatm5t = memb]s ( families t c>ry mutant alleles3 ,n[1 !re=e1 be x ,t x is ! s5se ( ! ,s5ate t-- 7#a7 ,,or: has improv$ & sav$ ! lives ( c\ntless wom5 worldwide & mu/ rema9 intact = ?is & future g5]ations2 7#b7 !re rema9 /rik+ sex & g5d] diff]5ces 9 _m diseases & conditions1 on :i* ,,or: %\ld cont9ue to focus1 includ+-- 7,a7 autoimmune diseases2 7,b7 canc]2 7,c7 c>diovascul> diseases2 7,d7 depression & bra9 disord]s2 7,e7 ,alzheim]'s disease2 7,f7 diabetes2 7,g7 *ronic diseases & disord]s2 7,h7 infecti\s diseases2 7,i7 obesity2 & 7,j7 addictive disord]s2 7#c7 ,,or: mu/ cont9ue to focus on ensur+ t ,,nih funds biom$ical rese>* t consid]s sex z a basic biological v>iable1 across ! rese>* spectrum f basic to cl9ical /udies2 & 7#d7 ! ,director ( ! ,,nih %\ld cont9ue to consult & involve ,,or: on all matt]s relat$ to ! influ5ce ( sex & g5d] on heal?1 especially ^? p]ta9+ to ! consid]ation ( sex z a biological v>iable 9 rese>* ) v]tebrate animals & humans4